CClinicalTrials.gg
CompletedNCT03149744Updated Aug 29, 2018

Mixed Methods Evaluation of a Novel Apnoea Event Detection Monitor

An observational study in Respiratory Rate, sponsored by PMD Solutions. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-08-29.

Sponsored by PMD Solutions · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
127
Ages
18 Years and older
Sex
All
01

Study summary

This investigation is looking at a currently available technology to see if it could have another use i.e. in helping to diagnose patients with sleep apnoea.

With 2-4% of the population suffering from this disease, and the current wait time for a test at approximately 20 weeks, it is hoped that a simple screening method could help speed up the process of finding these patients and getting them on treatment faster.

The current standard of care test involves a sleep study in the patients own home with a device with multiple parts and wires. The RespiraSense Sleep Screener is completely cableless and consists of one small, discrete unit attached to the patients side and a mobile device plugged in by the bed.

Patients at Queen Alexandra Hospital who are prescribed sleep studies will be invited to participate. The RespiraSense Sleep Screener data is only for comparison purposes and will have no effect on their clinical care.

If patients agree to participate they will undergo the sleep study with both devices in the same night and may be followed up with over the phone on their experiences with the test.

02

Conditions studied

  • Respiratory Rate
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients due to undergo standard of care home sleep testing

Inclusion criteria

  • Patients ≥ 18 Years
  • Patients due to undergo home monitoring to investigate presence of sleep apnoeic events
  • Patients able to provide informed consent to participate in this investigation

Exclusion criteria

Exclusion Criteria:

  • Patients with known respiratory disorders that are uncontrolled at the time of the sleep study
  • Patients allergic to medical grade skin adhesive
  • Patients on long term, oral steroid use
  • Pregnant women during second and third trimester
  • Patients presently on any sleep disorder therapy
  • Patients with any history of substance abuse (drug or alcohol) that may interfere with their ability to cooperate and comply with the investigation procedures
  • Patients with any disorder, including cognitive dysfunction, which would affect the ability to accurately complete questionnaires and freely give full informed consent
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
127 participants (actual)
Patient registry
No

Interventions

  • DeviceRespiraSense Sleep Screener

    RespiraSense will be worn at the same time as the standard of care SomnoScreen and it's results will be masked to the site team

05

What researchers measure

Primary outcomes

  1. Similarity to standard of care

    The mean error of the device relative to the overnight polysomnography tests ≥ 10 AHI

    Time frame: One night

Secondary outcomes

  1. Qualitative evaluation of RespiraSense

    to qualitatively evaluate the perceptions, values and opinions of the RS Sleep Screener device compared with the comparator to identify potential modifications to improve patient acceptance and to inform future implementation of the device within the NHS setting

    Time frame: One night

06

Study locations

1 site
  • Queen Alexandra Hospital
    Portsmouth, PO6 3LY, United Kingdom
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03149744
Lead sponsor
PMD Solutions
Collaborators
Portsmouth Hospitals NHS Trust
Responsible party
Sponsor
First posted
May 11, 2017
Start date
Feb 28, 2017
Primary completion
May 2, 2017
Completion
May 2, 2017
Last update
Aug 29, 2018

Study contacts

Anoop Chauhan
principal investigator · Portsmouth Hospitals NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion